Detoxification vs non-detoxification before starting an anti-CGRP monoclonal antibody in medication overuse headache.

Umberto PensatoCarlo BaraldiValentina Favoni Davide MascarellaEleonora MatteoGiorgia AndriniMaria Michela CainazzoPietro CortelliGiulia PierangeliSimona GuerzoniSabina Cevoli

Published in: Cephalalgia : an international journal of headache (2022)

Our results support the emerging evidence that anti-CGRP monoclonal antibodies may be effective in medication overuse headache patients irrespective of detoxification, yet further studies are needed to draw definitive conclusions.

Keyphrases

monoclonal antibody
end stage renal disease
healthcare
newly diagnosed
chronic kidney disease
prognostic factors
emergency department
squamous cell carcinoma
patient reported outcomes
locally advanced
rectal cancer
case control